What is kisqali medication. Aug 26, 2024 · Find patient medical information for Kisqali (ribociclib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings Apr 24, 2025 · Learn about cost, uses, and more for Kisqali (ribociclib), which is a prescription tablet that treats breast cancer in adults. KISQALI + hormone therapy work to stop your cancer from growing and spreading KISQALI is taken with an aromatase inhibitor (AI) or fulvestrant, which are hormone therapies. Kisqali contains the active ingredient ribociclib and belongs to the kinase inhibitor drug class. Mar 31, 2025 · Kisqali is a brand-name tablet prescribed for advanced breast cancer. Jul 2, 2025 · Kisqali (ribociclib) is a medication used to treat certain types of breast cancer, specifically hormone receptor–positive, human epidermal growth factor 2-negative (HR+, HER2-) breast cancer. Hormone therapy is a type of medication that is used to add, block, or remove hormones. Jan 22, 2025 · What to expect during Kisqali treatment Kisqali is prescribed with either Faslodex or an aromatase inhibitor, such as Arimidex (chemical name: anastrozole), Aromasin (chemical name: exemestane), and Femara (chemical name: letrozole). This helps to slow or stop the spread of cancer cells. Kisqali is a kinase inhibitor used in combination with other medicines to treat certain types of breast cancer in pre-/peri- and post-menopausal women. Learn about KISQALI, a treatment option for HR+, HER2- early breast cancer (eBC) and metastatic breast cancer (mBC). COMMON BRAND NAME (S): KISQALI. Kisqali and the aromatase inhibitors are pills taken by mouth. See full Prescribing & Safety Information. Includes ribociclib side effects, uses, doses, and interactions. It works by blocking a protein that causes cancer cells to grow and multiply. See full Prescribing and Safety Info. Nov 8, 2024 · Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes Kisqali side effects, interactions and indications. Aug 30, 2024 · Kisqali (ribociclib) is a medicine used for certain types of breast cancer. To understand how KISQALI works with an AI or fulvestrant to treat metastatic breast cancer (mBC), it's important to learn about the Jul 19, 2024 · Ribociclib (Kisqali) is a targeted treatment used to treat advanced breast cancer that is hormone receptor-positive and HER2-negative. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. Find answers to frequently asked questions about KISQALI as a treatment of metastatic breast cancer (mBC). Kisqali is used to treat breast cancer that is hormone receptor (HR)-positive and human epidermal growth factor receptor What is this medication? RIBOCICLIB (RYE boe SYE klib) treats breast cancer. Learn about the targeted therapy, ribociclib (Kisqali), including whether you might be offered it, how it’s given and the side effects you could have. It belongs to a drug class called CDK4/6 inhibitors, which help slow or stop cancer cells from growing. kmwifxk yhhgby yojk gszrf hgbo plsjy lzwf rmm ohgvp pkn